Winfried F. Pickl, MD, on the Future of a Novel Biomarker for CAR-T Responses in DLBCL

By Cecilia Brown, Winfried F. Pickl, MD - Last Updated: March 9, 2023

Winfried F. Pickl, MD, of the Institute of Immunology at the Medical University of Vienna, discusses potential future uses and implications of a novel biomarker to predict responses to chimeric antigen receptor T-cell therapy in patients with diffuse large B-cell lymphoma.

Advertisement

See part one of the interview on the novel biomarker here.

 

 

Advertisement
Advertisement
Advertisement